Bioventus Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 26, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	593	686	332	162	861	-
Market Cap Growth	-15.24%	106.84%	105.22%	-81.23%	-	-
Enterprise Value	885	1,086	775	605	1,054	-
Last Close Price	8.75	10.50	5.27	2.61	14.49	-
Forward PE	11.79	20.00	21.82	17.17	21.50	-
PS Ratio	1.04	1.20	0.65	0.32	2.00	-
PB Ratio	3.53	3.70	1.50	0.39	1.61	-
P/FCF Ratio	10.96	18.16	41.57	-	90.94	-
P/OCF Ratio	10.46	17.69	21.63	-	37.46	-
PEG Ratio	-	-	-	-	2.07	-
EV/Sales Ratio	1.57	1.90	1.51	1.18	2.45	-
EV/EBITDA Ratio	13.42	18.42	26.88	-	25.38	-
EV/EBIT Ratio	18.19	27.27	382.69	-	50.07	-
EV/FCF Ratio	16.55	28.75	97.14	-	111.28	-
Debt / Equity Ratio	1.65	1.92	1.90	1.06	0.71	1.42
Debt / EBITDA Ratio	4.81	5.50	11.81	719.64	8.23	3.83
Debt / FCF Ratio	6.38	9.42	52.70	-	39.72	3.70
Net Debt / Equity Ratio	1.44	1.69	1.74	0.99	0.62	0.82
Net Debt / EBITDA Ratio	4.53	5.33	13.30	-86.70	8.00	2.33
Net Debt / FCF Ratio	5.59	8.32	48.07	-16.20	35.09	2.13
Asset Turnover	0.77	0.75	0.47	0.39	0.50	0.66
Inventory Turnover	1.95	2.01	2.09	2.47	2.82	3.11
Quick Ratio	1.07	0.80	0.91	0.55	0.93	1.43
Current Ratio	1.74	1.31	1.53	0.90	1.46	1.73
Return on Equity (ROE)	6.38%	-21.55%	-38.27%	-30.58%	3.38%	10.16%
Return on Assets (ROA)	4.13%	3.24%	0.12%	-1.67%	1.53%	2.82%
Return on Invested Capital (ROIC)	8.02%	7.21%	0.29%	-4.12%	3.73%	7.22%
Return on Capital Employed (ROCE)	9.00%	7.70%	0.30%	-3.20%	2.00%	5.90%
Earnings Yield	1.74%	-4.89%	-47.08%	-98.15%	2.25%	-
FCF Yield	9.12%	5.51%	2.40%	-15.50%	1.10%	-
Payout Ratio	-	-	-	-	-	121.18%
Buyback Yield / Dilution	-6.27%	-3.03%	-2.05%	-35.00%	-828.01%	-

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q